IBDEI0V8 ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,15442,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15442,1,3,0)
 ;;=3^588.89
 ;;^UTILITY(U,$J,358.3,15442,1,4,0)
 ;;=4^HYPERPARATHYROID W/ IMPAIR REN FNC
 ;;^UTILITY(U,$J,358.3,15442,2)
 ;;=^88036
 ;;^UTILITY(U,$J,358.3,15443,0)
 ;;=356.9^^95^940^13
 ;;^UTILITY(U,$J,358.3,15443,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15443,1,3,0)
 ;;=3^356.9
 ;;^UTILITY(U,$J,358.3,15443,1,4,0)
 ;;=4^IDIO PERIPH NEURPTHY NOS
 ;;^UTILITY(U,$J,358.3,15443,2)
 ;;=^123931
 ;;^UTILITY(U,$J,358.3,15444,0)
 ;;=588.89^^95^940^14
 ;;^UTILITY(U,$J,358.3,15444,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15444,1,3,0)
 ;;=3^588.89
 ;;^UTILITY(U,$J,358.3,15444,1,4,0)
 ;;=4^IMPAIR REN FUNCT DIS NEC
 ;;^UTILITY(U,$J,358.3,15444,2)
 ;;=^88036
 ;;^UTILITY(U,$J,358.3,15445,0)
 ;;=411.1^^95^940^15
 ;;^UTILITY(U,$J,358.3,15445,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15445,1,3,0)
 ;;=3^411.1
 ;;^UTILITY(U,$J,358.3,15445,1,4,0)
 ;;=4^INTERMED CORONARY SYND
 ;;^UTILITY(U,$J,358.3,15445,2)
 ;;=^7455
 ;;^UTILITY(U,$J,358.3,15446,0)
 ;;=428.1^^95^940^16
 ;;^UTILITY(U,$J,358.3,15446,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15446,1,3,0)
 ;;=3^428.1
 ;;^UTILITY(U,$J,358.3,15446,1,4,0)
 ;;=4^LEFT HEART FAILURE
 ;;^UTILITY(U,$J,358.3,15446,2)
 ;;=^68721
 ;;^UTILITY(U,$J,358.3,15447,0)
 ;;=581.9^^95^940^17
 ;;^UTILITY(U,$J,358.3,15447,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15447,1,3,0)
 ;;=3^581.9
 ;;^UTILITY(U,$J,358.3,15447,1,4,0)
 ;;=4^NEPHROTIC SYNDROME NOS
 ;;^UTILITY(U,$J,358.3,15447,2)
 ;;=^82357
 ;;^UTILITY(U,$J,358.3,15448,0)
 ;;=278.01^^95^940^18
 ;;^UTILITY(U,$J,358.3,15448,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15448,1,3,0)
 ;;=3^278.01
 ;;^UTILITY(U,$J,358.3,15448,1,4,0)
 ;;=4^OBESITY,MORBID
 ;;^UTILITY(U,$J,358.3,15448,2)
 ;;=^84844
 ;;^UTILITY(U,$J,358.3,15449,0)
 ;;=278.00^^95^940^19
 ;;^UTILITY(U,$J,358.3,15449,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15449,1,3,0)
 ;;=3^278.00
 ;;^UTILITY(U,$J,358.3,15449,1,4,0)
 ;;=4^OBESITY,UNSPEC
 ;;^UTILITY(U,$J,358.3,15449,2)
 ;;=^84823
 ;;^UTILITY(U,$J,358.3,15450,0)
 ;;=278.02^^95^940^20
 ;;^UTILITY(U,$J,358.3,15450,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15450,1,3,0)
 ;;=3^278.02
 ;;^UTILITY(U,$J,358.3,15450,1,4,0)
 ;;=4^OVERWEIGHT
 ;;^UTILITY(U,$J,358.3,15450,2)
 ;;=^332745
 ;;^UTILITY(U,$J,358.3,15451,0)
 ;;=423.9^^95^940^21
 ;;^UTILITY(U,$J,358.3,15451,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15451,1,3,0)
 ;;=3^423.9
 ;;^UTILITY(U,$J,358.3,15451,1,4,0)
 ;;=4^PERICARDIAL DISEASE NOS
 ;;^UTILITY(U,$J,358.3,15451,2)
 ;;=^123813
 ;;^UTILITY(U,$J,358.3,15452,0)
 ;;=443.9^^95^940^22
 ;;^UTILITY(U,$J,358.3,15452,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15452,1,3,0)
 ;;=3^443.9
 ;;^UTILITY(U,$J,358.3,15452,1,4,0)
 ;;=4^PERIPH VASCULAR DIS NOS
 ;;^UTILITY(U,$J,358.3,15452,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,15453,0)
 ;;=272.0^^95^940^23
 ;;^UTILITY(U,$J,358.3,15453,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15453,1,3,0)
 ;;=3^272.0
 ;;^UTILITY(U,$J,358.3,15453,1,4,0)
 ;;=4^PURE HYPERCHOLESTEROLEM
 ;;^UTILITY(U,$J,358.3,15453,2)
 ;;=^59973
 ;;^UTILITY(U,$J,358.3,15454,0)
 ;;=272.1^^95^940^24
 ;;^UTILITY(U,$J,358.3,15454,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15454,1,3,0)
 ;;=3^272.1
 ;;^UTILITY(U,$J,358.3,15454,1,4,0)
 ;;=4^PURE HYPERGLYCERIDEMIA
 ;;^UTILITY(U,$J,358.3,15454,2)
 ;;=^101303
 ;;^UTILITY(U,$J,358.3,15455,0)
 ;;=588.0^^95^940^25
 ;;^UTILITY(U,$J,358.3,15455,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,15455,1,3,0)
 ;;=3^588.0
 ;;^UTILITY(U,$J,358.3,15455,1,4,0)
 ;;=4^RENAL OSTEODYSTROPHY
 ;;^UTILITY(U,$J,358.3,15455,2)
 ;;=^104747
